Panel Discussion: Identifying Targets to Simultaneously Tackle Neuroinflammation & Neurodegeneration
Time: 11:15 am
day: Day Two
Details:
• Debating targets impacting both neuroinflammation and neurodegeneration: RIPKI, ferroptosis, TDP43
• Discussing strategy for targeting two pathological processes simultaneously
• Outlining opportunities to de-risk future clinical trials
• Debating the future of neuroinflammation modulators as combination therapies in light of recent Alzheimer’s Disease therapeutic approvals
